Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders

Neuroscience Letters

Volumn 529, Issue 2, 2012, Pages 139-143

  Uher, Tomas ^a   Bob, Petr ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Anxiety; Cerebrospinal fluid; Depression; NSE; S100B protein

Indexed keywords

ALBUMIN; AMITRIPTYLINE; C REACTIVE PROTEIN; CITALOPRAM; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIRTAZAPINE; NEURON SPECIFIC ENOLASE; PROTEIN S100B; TRAZODONE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPILEPSY; FEMALE; GLIA; HUMAN; INFLAMMATORY DISEASE; MALE; NEUROLOGIC DISEASE; NON INFLAMMATORY NEUROLOGICAL DISORDER; PATHOPHYSIOLOGY; PRIMARY HEADACHE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PSYCHOLOGIC TEST; PSYCHOMETRY; SELF-RATING ANXIETY SCALE; SPONDYLOSIS; SYMPTOM; VERTIGO;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; NERVE GROWTH FACTORS; NERVOUS SYSTEM DISEASES; PSYCHOMETRICS; S100 PROTEINS;

EID: 84868002417     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.09.003     Document Type: Article

References (43)

1. Adami C., Sorci G., Blasi E., Agneletti A.L., Bistoni F., Donato R. S100B expression in and effects on microglia. Glia 2001, 33:131-142.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatry Press, Washington, DC. 4th ed.
3. Anisman H., Du L., Palkovits M., Faludi G., Kovacs G.G., Szontagh-Kishazi P., Merali Z., Poulter M.O. Serotonin receptor subtype and p11mRNA expression in stress-relevant brain regions of suicide and control subjects. Journal of Psychiatry and Neuroscience 2008, 33:131-141.
4. Arolt V., Peters M., Erfurth A., Wiesmann M., Missler U., Rudolf S., Kirchner H., Rothermundt M. S100B and response to treatment in major depression: a pilot study. European Neuropsychopharmacology 2003, 13:235-239.
5. Bagby R.M., Taylor G.J., Parker J.D. The twenty-item Toronto Alexithymia Scale. II: convergent, discriminant, and concurrent validity. Journal of Psychosomatic Research 1994, 38:33-40.
6. Banasr M., Duman R.S. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry 2008, 64:863-870.
7. Beck A.T., Steer R.A., Brown G.K. Manual for Beck Depression Inventory-II. 1996, Psychological Corporation, San Antonio, TX.
8. Bernard R., Kerman I.A., Thompson R.C., Jones E.G., Bunney W.E., Barchas J.D., Schatzberg A.F., Myers R.M., Akil H., Watson S.J. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Molecular Psychiatry 2011, 16:634-646.
9. Donato R. S100: a multigenic family of calcium-modulated proteins of the EFh and type with intracellular and extracellular functional roles. International Journal of Biochemistry and Cell Biology 2001, 33:637-668.
10. Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. Journal of Biological Chemistry 2000, 275:40096-40105.
11. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biological Psychiatry 2010, 67:446-457.
12. Emanuele E., D'Angelo A., Tomaino C., Binetti G., Ghidoni R., Politi P., Bernardi L., Maletta R., Bruni A.C., Geroldi D. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Archives of Neurology 2005, 62:1734-1736.
13. Emanuele E., Martinelli V., Carlin M.V., Fugazza E., Barale F., Politi P. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders. Neuroscience Letters 2011, 487:99-102.
14. Falcone T., Fazio V., Lee C., Simon B., Franco K., Marchi N., Janigro D. Serum S100B: a potential biomarker for suicidality in adolescents?. PLoS ONE 2010, 5:e11089.
15. Gerlach R., Demel G., Konig H.G., Gross U., Prehn J.H., Raabe A., Seifert V., Kögel D. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 2006, 141:1697-1701.
16. Grabe H.J., Ahrens N., Rose H.J., Kessler C., Freyberger H.J. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 2001, 44:88-90.
17. Hetzel G., Moeller O., Evers S., Erfurth A., Ponath G., Arolt V., Rothermundt M. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology 2005, 178:161-166.
18. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
19. Kleindienst A., McGinn M.J., Harvey H.B., Colello R.J., Hamm R.J., Bullock M.R. Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. Journal of Neurotrauma 2005, 22:645-655.
20. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., ffrench-Mullen J., Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 2009, 14:175-189.
21. Li Y., Barger S.W., Liu L., Mrak R.E., Griffin W.S. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. Journal of Neurochemistry 2000, 74:143-150.
22. Luo K.R., Hong C.J., Liou Y.J., Hou S.J., Huang Y.H., Tsai S.J. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34:1433-1439.
23. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
24. Missler U., Wiesmann M. Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results. European Journal of Clinical Chemistry and Clinical Biochemistry 1995, 33:743-748.
25. Rajkowska G. Dysfunction in neural circuits involved in the pathophysiology of mood disorders: postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry 2000, 48:766-777.
26. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clinica Chimica Acta 2001, 310:173-186.
27. Rong H., Wang G., Liu T., Wang H., Wan Q., Weng S. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. International Journal of Molecular Sciences 2010, 11:5310-5322.
28. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., Rudolf S., Kirchner H. S-100B is increased in melancholic but not in non-melancholic major depression. Journal of Affective Disorders 2001, 66:89-93.
29. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microscopy Research and Technique 2003, 60:614-632.
30. Sakatani S., Seto-Ohshima A., Itohara S., Hirase H. Impact of S100B on local field potential patterns in anesthetized and kainic acid-induced seizure conditions in vivo. European Journal of Neuroscience 2007, 25:1144-1154.
31. Schroeter M.L., Abdul-Khaliq H., Krebs M., Diefenbacher A., Blasig I.E. Serum markers support disease-specific glial pathology in major depression. Journal of Affective Disorders 2008, 111:271-280.
32. Schroeter M.L., Abdul-Khaliq H., Krebs M., Diefenbacher A., Blasig I.E. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia-original research and meta-analysis. Psychiatry Research 2009, 167:66-72.
33. Schroeter M.L., Abdul-Khaliq H., Sacher J., Steiner J., Blasig I.E., Mueller K. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovascular Psychiatry and Neurology 2010, 2010:780645.
34. Schroeter M.L., Steiner J., Mueller K. Glial pathology is modified by age in mood disorders-a systematic meta-analysis of serum S100B in vivo studies. Journal of Affective Disorders 2011, 134:32-38.
35. Shapiro L.A., Bialowas-McGoey L.A., Whitaker-Azmitia P.M. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in down syndrome and Alzheimer's disease: studies in an S100B overexpressing mouse model. Cardiovascular Psychiatry and Neurology 2010, 2010. pii: 153657.
36. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Kanava J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33.
37. Sorci G., Giovannini G., Riuzzi F., Bonifazi P., Zelante T., Zagarella S., Bistoni F., Donato R., Romani L. The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathogens 2011, 7:e1001315.
38. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neuroscience 2007, 8:2.
39. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
40. van Eldik L.J., Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restorative Neurology and Neuroscience 2003, 21:97-108.
41. van den Hove D.L., Steinbusch H.W., Bruschettini M., Gazzolo D., Frulio R., Scheepens A., Prickaerts J., Blanco C.E. Prenatal stress reduces S100B in the neonatal rat hippocampus. Neuroreport 2006, 17:1077-1080.
42. Ye Y., Wang G., Wang H., Wang X. Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression. Neuroscience Letters 2011, 503:15-19.
43. Zung W.W.K. A rating instrument for anxiety disorders. Psychosomatics 1971, 12:371-379.